Unknown

Dataset Information

Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.


ABSTRACT:

Background

The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatment of CVDs on national essential medicines lists (NEMLs) of LMICs and potential determinants for selection.

Methods

Only operational NEMLs were considered eligible for this study. A selection of medicines listed under "cardiovascular medicines" or "blood products and plasma substitutes" in the NEMLs were included if they were present on international guidelines for the prevention and treatment of CVDs (hyperlipidemia, hypertension, platelet inhibition, ischemic stroke, stable ischemic heart disease, acute coronary syndro

SUBMITTER: Bazargani YT 

PROVIDER: S-EPMC6019804 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature